PUMA and BIM Are Required for Oncogene Inactivation–Induced Apoptosis-Reference-Cited by-同舟云学术

PUMA and BIM Are Required for Oncogene Inactivation–Induced Apoptosis

Published:2013-03-26 Issue:268 Volume:6 Page:
ISSN:1945-0877
Container-title:Science Signaling
language:en
Short-container-title:Sci. Signal.

Author:

Bean Gregory R.¹²,Ganesan Yogesh Tengarai¹,Dong Yiyu¹,Takeda Shugaku¹,Liu Han¹,Chan Po M.¹,Huang Yafen¹,Chodosh Lewis A.³,Zambetti Gerard P.⁴,Hsieh James J.-D.¹⁵,Cheng Emily H.-Y.¹⁶⁷

Affiliation:

1. Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

2. Division of Biology & Biomedical Sciences, Washington University, St. Louis, MO 63110, USA.

3. Department of Cancer Biology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.

4. St. Jude Children’s Research Hospital, Memphis, TN 38105, USA.

5. Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

6. Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

7. Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Cornell University, New York, NY 10065, USA.

Abstract

Combining drugs that inhibit antiapoptotic proteins with oncogenic kinase inhibitors may overcome drug resistance in cancer therapy.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference55 articles.

1. A Blueprint for Advancing Genetics-Based Cancer Therapy

2. Addiction to Oncogenes--the Achilles Heal of Cancer

3. The BCL-2 protein family: opposing activities that mediate cell death

4. The expanding role of mitochondria in apoptosis.;Wang X.;Genes Dev.,2001

5. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coexpression of TP53, BIM, and PTEN Enhances the Therapeutic Efficacy of Non-Small-Cell Lung Cancer;Biomacromolecules;2024-01-18

2. Epithelial to Mesenchymal Transition (EMT);Multi‐Drug Resistance in Cancer;2023-07-17

3. Potential Chemopreventive Role of Pterostilbene in Its Modulation of the Apoptosis Pathway;International Journal of Molecular Sciences;2023-06-03

4. Apoptotic cell death in disease—Current understanding of the NCCD 2023;Cell Death & Differentiation;2023-04-26

5. Repurposing of triamterene as a histone deacetylase inhibitor to overcome cisplatin resistance in lung cancer treatment;Journal of Cancer Research and Clinical Oncology;2023-03-11